comparemela.com

Latest Breaking News On - Michael miao - Page 1 : comparemela.com

Fintechs Are Under Pressure to Stop Russian Sanctions Evasion This Start-Up Raised $94 Million to Help

Fintech Seon, Which Specializes In Fraud Prevention, Acquires $94M In Funding

Fintech Seon, Which Specializes In Fraud Prevention, Acquires $94M In Funding
crowdfundinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from crowdfundinsider.com Daily Mail and Mail on Sunday newspapers.

SEON Raises $94 Million Series B to Address Exponential Growth of Online Fraud

SEON Raises $94 Million Series B to Address Exponential Growth of Online Fraud
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Anglo-Hungarian anti-fraud platform SEON pulls in a $94M Series B led by IVP – TechCrunch

Last year, SEON, which has an anti-fraud platform designed to fight accounts raised a $12 million Series A. It does this by looking at a customer’s ‘digital footprint’ – especially their social media – in order to weed out false accounts and thus prevent fraudulent transactions. Clients included Patreon, AirFrance, Rivalry and Ladbrokes. The London-based […]

H1 Closes $58M Series B Funding – FinSMEs

H1, a NYC-based global platform for the healthcare ecosystem, closed a $58m Series B round of funding. The round was co-led by IVP and Menlo Ventures with participation from Transformation Capital, Lux Capital, Lead Edge Capital, Novartis dRx and YC. In conjunction with the funding, Somesh Dash, General Partner at IVP, is joining the H1 board of directors. IVP Partner Michael Miao, Menlo Ventures Partner JP Sanday and Lux Partner Deena Shakir are also joining as board observers. Led by co-founders Ariel Katz and Ian Sax, H1 connects parties within the healthcare ecosystem. Its platform empowers the life sciences industry with 9 million healthcare provider (HCP) profiles worldwide from professional, scholarly, clinical, and social sources, as well as complete global and therapeutic area coverage. H1 utilizes data science and intelligence to draw out unique insights and accelerate outcomes for medical affairs, commercial and marketing organizations. .

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.